UD-014

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameUD-014
Drug Alias NameSSAO/VAP-1 inhibitor (diabetic nephropathy)UD-014
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAmine oxidase, copper containing inhibitors
TargetsAmine oxidase, copper containing
Therapy Area/IndicationsDiabetic NephropathiesMetabolic Dysfunction-Associated Steatotic Liver Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUbe Industries Ltd
China Registration ClassN/A

Develop Information

Active CompaniesNovo Nordisk A/SUbe Industries Ltd
Inactive CompaniesN/A
Active IndicationsDiabetic NephropathiesMetabolic Dysfunction-Associated Steatotic Liver Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A